business services

Successful acquisition of EUDRAC by Quality by design

We assisted Quality by Design (QbD Group), a leading provider of life science services, in its acquisition of regulatory affairs and pharmacovigilance specialist EUDRAC as lead corporate finance advisor


  • Identify and evaluate potential targets that align with QbD's strategic objectives
  • Initiate discussions, develop assessments, and submit letters of intent with identified target companies
  • Coordinate and execute due diligence and final purchase agreement negotiations

Result / Success

By joining the QbD Group, EUDRAC Ltd. will gain access to a broader customer base and the necessary infrastructure to ensure further growth. EUDRAC Ltd. will be renamed QbD Ltd.  

In turn, this acquisition will expand QbD Group's regulatory affairs department to better serve its pharmaceutical customers, including those developing advanced therapy medicinal products (ATMPs). 

Your contact

Andre Wassmann

Neuer Zollhof 3
40221 Düsseldorf

Further references

Get in touch with us

Contact now